TEAM

Prof. Andrés Cervantes is Head of the Medical Oncology Service at the University Hospital of Valencia. His training as a Resident Internal Physician was carried out at the University Hospital of Valencia. After completing this period he obtained a predoctoral fellowship at the Free University Hospital in Amsterdam, where he obtained his Doctorate in the cell pharmacology laboratory, with a work on resistance to multiple drugs.

Dr. Cervantes is Professor of Medicine at the University of Valencia. Since May 2017 he is the General Director of the Institute of Health Research – INCLIVA.

His main areas of interest and research are gastrointestinal and gynecological cancer, as well as phase I trials and development of new drugs. He is a clinical researcher of rectal cancer, a subject in which he has developed several publications on the quality of multidisciplinary work, the evaluation of the quality of mesorectal surgery, or how to optimize the ideal choice of initial therapy and, how to treat cancer of the upper third of the rectum. He currently works in the role of liquid biopsy as a marker of minimal residual disease in colon cancer. He is the author of more than 300 articles and reviews of works published in different journals. He is also editor of the journal Cancer Treatment Reviews. He has been director of Education at ESMO, European Society of Medical Oncology, (society of oncologists with almost 24,000 members worldwide) and associate editor of the Annals of Oncology, the European magazine with the highest impact on oncology. He is currently President Elect of ESMO.